> top > docs > PubMed:11320058 > annotations

PubMed:11320058 JSONTXT

Annnotations TAB JSON ListView MergeView

Glycan-Motif

Id Subject Object Predicate Lexical cue
T1 87-92 https://glytoucan.org/Structures/Glycans/G01187XC denotes Le(x)

GlyCosmos6-Glycan-Motif-Image

Id Subject Object Predicate Lexical cue image
T1 87-92 Glycan_Motif denotes Le(x) https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G01187XC

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-104 Sentence denotes N-linked oligosaccharides of cobra venom factor contain novel alpha(1-3)galactosylated Le(x) structures.
TextSentencer_T2 105-255 Sentence denotes Cobra venom factor (CVF), a nontoxic, complement-activating glycoprotein in cobra venom, is a functional analog of mammalian complement component C3b.
TextSentencer_T3 256-417 Sentence denotes The carbohydrate moiety of CVF consists exclusively of N-linked oligosaccharides with terminal alpha1-3-linked galactosyl residues, which are antigenic in human.
TextSentencer_T4 418-527 Sentence denotes CVF has potential for several medical applications, including targeted cell killing and complement depletion.
TextSentencer_T5 528-606 Sentence denotes Here, we report a detailed structural analysis of the oligosaccharides of CVF.
TextSentencer_T6 607-807 Sentence denotes The structures of the oligosaccharides were determined by lectin affinity chromatography, antibody affinity blotting, compositional and methylation analyses, and high-resolution (1)H-NMR spectroscopy.
TextSentencer_T7 808-995 Sentence denotes Approximately 80% of the oligosaccharides are diantennary complex-type, approximately 12% are tri- and tetra-antennary complex-type, and approximately 8% are oligomannose type structures.
TextSentencer_T8 996-1202 Sentence denotes The majority of the complex-type oligosaccharides terminate in Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1, a unique carbohydrate structural feature abundantly present in the glycoproteins of cobra venom.
T1 0-104 Sentence denotes N-linked oligosaccharides of cobra venom factor contain novel alpha(1-3)galactosylated Le(x) structures.
T2 105-255 Sentence denotes Cobra venom factor (CVF), a nontoxic, complement-activating glycoprotein in cobra venom, is a functional analog of mammalian complement component C3b.
T3 256-417 Sentence denotes The carbohydrate moiety of CVF consists exclusively of N-linked oligosaccharides with terminal alpha1-3-linked galactosyl residues, which are antigenic in human.
T4 418-527 Sentence denotes CVF has potential for several medical applications, including targeted cell killing and complement depletion.
T5 528-606 Sentence denotes Here, we report a detailed structural analysis of the oligosaccharides of CVF.
T6 607-807 Sentence denotes The structures of the oligosaccharides were determined by lectin affinity chromatography, antibody affinity blotting, compositional and methylation analyses, and high-resolution (1)H-NMR spectroscopy.
T7 808-995 Sentence denotes Approximately 80% of the oligosaccharides are diantennary complex-type, approximately 12% are tri- and tetra-antennary complex-type, and approximately 8% are oligomannose type structures.
T8 996-1202 Sentence denotes The majority of the complex-type oligosaccharides terminate in Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1, a unique carbohydrate structural feature abundantly present in the glycoproteins of cobra venom.
T1 0-104 Sentence denotes N-linked oligosaccharides of cobra venom factor contain novel alpha(1-3)galactosylated Le(x) structures.
T2 105-255 Sentence denotes Cobra venom factor (CVF), a nontoxic, complement-activating glycoprotein in cobra venom, is a functional analog of mammalian complement component C3b.
T3 256-417 Sentence denotes The carbohydrate moiety of CVF consists exclusively of N-linked oligosaccharides with terminal alpha1-3-linked galactosyl residues, which are antigenic in human.
T4 418-527 Sentence denotes CVF has potential for several medical applications, including targeted cell killing and complement depletion.
T5 528-606 Sentence denotes Here, we report a detailed structural analysis of the oligosaccharides of CVF.
T6 607-807 Sentence denotes The structures of the oligosaccharides were determined by lectin affinity chromatography, antibody affinity blotting, compositional and methylation analyses, and high-resolution (1)H-NMR spectroscopy.
T7 808-995 Sentence denotes Approximately 80% of the oligosaccharides are diantennary complex-type, approximately 12% are tri- and tetra-antennary complex-type, and approximately 8% are oligomannose type structures.
T8 996-1202 Sentence denotes The majority of the complex-type oligosaccharides terminate in Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1, a unique carbohydrate structural feature abundantly present in the glycoproteins of cobra venom.

GlyCosmos6-Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 87-92 https://glytoucan.org/Structures/Glycans/G01187XC denotes Le(x)

GlycoBiology-FMA

Id Subject Object Predicate Lexical cue
_T1 9-25 FMAID:196731 denotes oligosaccharides
_T2 9-25 FMAID:82742 denotes oligosaccharides
_T3 165-177 FMAID:62925 denotes glycoprotein
_T4 165-177 FMAID:167256 denotes glycoprotein
_T5 260-272 FMAID:82737 denotes carbohydrate
_T6 260-272 FMAID:197276 denotes carbohydrate
_T7 320-336 FMAID:82742 denotes oligosaccharides
_T8 320-336 FMAID:196731 denotes oligosaccharides
_T9 582-598 FMAID:196731 denotes oligosaccharides
_T10 582-598 FMAID:82742 denotes oligosaccharides
_T11 629-645 FMAID:196731 denotes oligosaccharides
_T12 629-645 FMAID:82742 denotes oligosaccharides
_T13 697-705 FMAID:167180 denotes antibody
_T14 725-738 FMAID:50603 denotes compositional
_T15 725-738 FMAID:146309 denotes compositional
_T16 833-849 FMAID:82742 denotes oligosaccharides
_T17 833-849 FMAID:196731 denotes oligosaccharides
_T18 1029-1045 FMAID:82742 denotes oligosaccharides
_T19 1029-1045 FMAID:196731 denotes oligosaccharides
_T20 1115-1127 FMAID:197276 denotes carbohydrate
_T21 1115-1127 FMAID:82737 denotes carbohydrate
_T22 1173-1186 FMAID:62925 denotes glycoproteins
_T23 1173-1186 FMAID:167256 denotes glycoproteins

GlycoBiology-NCBITAXON

Id Subject Object Predicate Lexical cue
T1 911-916 http://purl.bioontology.org/ontology/NCBITAXON/85284 denotes tetra
T2 911-916 http://purl.bioontology.org/ontology/NCBITAXON/1310384 denotes tetra
T3 917-926 http://purl.bioontology.org/ontology/NCBITAXON/293542 denotes antennary

GO-BP

Id Subject Object Predicate Lexical cue
T1 143-164 http://purl.obolibrary.org/obo/GO_0006956 denotes complement-activating
T2 489-501 http://purl.obolibrary.org/obo/GO_0001906 denotes cell killing
T3 743-754 http://purl.obolibrary.org/obo/GO_0032259 denotes methylation

GO-MF

Id Subject Object Predicate Lexical cue
T1 697-705 http://purl.obolibrary.org/obo/GO_0003823 denotes antibody

GO-CC

Id Subject Object Predicate Lexical cue
T1 489-493 http://purl.obolibrary.org/obo/GO_0005623 denotes cell

UBERON-AE

Id Subject Object Predicate Lexical cue
T1 35-40 http://purl.obolibrary.org/obo/UBERON_0007113 denotes venom
T2 111-116 http://purl.obolibrary.org/obo/UBERON_0007113 denotes venom
T3 187-192 http://purl.obolibrary.org/obo/UBERON_0007113 denotes venom
T4 1196-1201 http://purl.obolibrary.org/obo/UBERON_0007113 denotes venom

EDAM-topics

Id Subject Object Predicate Lexical cue
T1 260-272 http://edamontology.org/topic_0152 denotes carbohydrate
T2 342-350 http://edamontology.org/topic_0749 denotes terminal
T3 398-407 http://edamontology.org/topic_2830 denotes antigenic
T4 411-416 http://edamontology.org/topic_2815 denotes human
T5 480-488 http://edamontology.org/topic_0154 denotes targeted
T6 555-574 http://edamontology.org/topic_0081 denotes structural analysis
T7 790-793 http://edamontology.org/topic_0593 denotes NMR
T8 790-806 http://edamontology.org/topic_0593 denotes NMR spectroscopy
T9 794-806 http://edamontology.org/topic_0593 denotes spectroscopy
T10 1046-1055 http://edamontology.org/topic_0749 denotes terminate
T11 1115-1127 http://edamontology.org/topic_0152 denotes carbohydrate

EDAM-DFO

Id Subject Object Predicate Lexical cue
T1 93-103 http://edamontology.org/data_0883 denotes structures
T2 378-386 http://edamontology.org/data_1756 denotes residues
T3 537-543 http://edamontology.org/data_2048 denotes report
T4 555-565 http://edamontology.org/data_0883 denotes structural
T5 555-574 http://edamontology.org/operation_2480 denotes structural analysis
T6 566-574 http://edamontology.org/operation_2945 denotes analysis
T7 611-621 http://edamontology.org/data_0883 denotes structures
T8 743-763 http://edamontology.org/operation_3204 denotes methylation analyses
T9 984-994 http://edamontology.org/data_0883 denotes structures
T10 1115-1138 http://edamontology.org/data_1462 denotes carbohydrate structural
T11 1128-1138 http://edamontology.org/data_0883 denotes structural
T12 1139-1146 http://edamontology.org/data_1255 denotes feature

GlyTouCan-IUPAC

Id Subject Object Predicate Lexical cue
GlycanIUPAC_T1 902-905 "http://rdf.glycoinfo.org/glycan/G44384WF" denotes tri
GlycanIUPAC_T2 902-905 "http://rdf.glycoinfo.org/glycan/G37452RG" denotes tri
GlycanIUPAC_T3 902-905 "http://rdf.glycoinfo.org/glycan/G56296FC" denotes tri
GlycanIUPAC_T4 902-905 "http://rdf.glycoinfo.org/glycan/G44877OG" denotes tri
GlycanIUPAC_T5 902-905 "http://rdf.glycoinfo.org/glycan/G22627HB" denotes tri
GlycanIUPAC_T6 902-905 "http://rdf.glycoinfo.org/glycan/G76069IP" denotes tri
GlycanIUPAC_T7 902-905 "http://rdf.glycoinfo.org/glycan/G77301LL" denotes tri
GlycanIUPAC_T8 902-905 "http://rdf.glycoinfo.org/glycan/G92446EV" denotes tri
GlycanIUPAC_T9 902-905 "http://rdf.glycoinfo.org/glycan/G93798MG" denotes tri
GlycanIUPAC_T10 902-905 "http://rdf.glycoinfo.org/glycan/G19180VS" denotes tri
GlycanIUPAC_T11 902-905 "http://rdf.glycoinfo.org/glycan/G00261CT" denotes tri
GlycanIUPAC_T12 902-905 "http://rdf.glycoinfo.org/glycan/G23925MM" denotes tri
GlycanIUPAC_T13 902-905 "http://rdf.glycoinfo.org/glycan/G27176LA" denotes tri
GlycanIUPAC_T14 902-905 "http://rdf.glycoinfo.org/glycan/G76226NF" denotes tri
GlycanIUPAC_T15 902-905 "http://rdf.glycoinfo.org/glycan/G80006GG" denotes tri
GlycanIUPAC_T16 902-905 "http://rdf.glycoinfo.org/glycan/G99968MY" denotes tri
GlycanIUPAC_T17 902-905 "http://rdf.glycoinfo.org/glycan/G67393MB" denotes tri
GlycanIUPAC_T18 902-905 "http://rdf.glycoinfo.org/glycan/G09037VU" denotes tri
GlycanIUPAC_T19 902-905 "http://rdf.glycoinfo.org/glycan/G19508PX" denotes tri
GlycanIUPAC_T20 902-905 "http://rdf.glycoinfo.org/glycan/G40619ZS" denotes tri
GlycanIUPAC_T21 902-905 "http://rdf.glycoinfo.org/glycan/G19507SX" denotes tri
GlycanIUPAC_T22 902-905 "http://rdf.glycoinfo.org/glycan/G50874XT" denotes tri
GlycanIUPAC_T23 902-905 "http://rdf.glycoinfo.org/glycan/G60561GL" denotes tri
GlycanIUPAC_T24 902-905 "http://rdf.glycoinfo.org/glycan/G98788DE" denotes tri
GlycanIUPAC_T25 902-905 "http://rdf.glycoinfo.org/glycan/G85696MX" denotes tri
GlycanIUPAC_T26 902-905 "http://rdf.glycoinfo.org/glycan/G82652IN" denotes tri
GlycanIUPAC_T27 902-905 "http://rdf.glycoinfo.org/glycan/G95603AK" denotes tri
GlycanIUPAC_T28 902-905 "http://rdf.glycoinfo.org/glycan/G87993NJ" denotes tri
GlycanIUPAC_T29 902-905 "http://rdf.glycoinfo.org/glycan/G85533KK" denotes tri
GlycanIUPAC_T30 902-905 "http://rdf.glycoinfo.org/glycan/G78142NX" denotes tri
GlycanIUPAC_T31 902-905 "http://rdf.glycoinfo.org/glycan/G94944YR" denotes tri
GlycanIUPAC_T32 902-905 "http://rdf.glycoinfo.org/glycan/G60875EM" denotes tri
GlycanIUPAC_T33 902-905 "http://rdf.glycoinfo.org/glycan/G58390SD" denotes tri
GlycanIUPAC_T34 902-905 "http://rdf.glycoinfo.org/glycan/G46314WZ" denotes tri
GlycanIUPAC_T35 902-905 "http://rdf.glycoinfo.org/glycan/G35012MY" denotes tri
GlycanIUPAC_T36 902-905 "http://rdf.glycoinfo.org/glycan/G11847VZ" denotes tri
GlycanIUPAC_T37 902-905 "http://rdf.glycoinfo.org/glycan/G91662AB" denotes tri
GlycanIUPAC_T38 902-905 "http://rdf.glycoinfo.org/glycan/G99771WN" denotes tri
GlycanIUPAC_T39 902-905 "http://rdf.glycoinfo.org/glycan/G92389SI" denotes tri
GlycanIUPAC_T40 902-905 "http://rdf.glycoinfo.org/glycan/G40437FC" denotes tri
GlycanIUPAC_T41 902-905 "http://rdf.glycoinfo.org/glycan/G00509WV" denotes tri
GlycanIUPAC_T42 902-905 "http://rdf.glycoinfo.org/glycan/G36565LB" denotes tri
GlycanIUPAC_T43 902-905 "http://rdf.glycoinfo.org/glycan/G50335BH" denotes tri
GlycanIUPAC_T44 902-905 "http://rdf.glycoinfo.org/glycan/G87946UV" denotes tri
GlycanIUPAC_T45 902-905 "http://rdf.glycoinfo.org/glycan/G99103VB" denotes tri
GlycanIUPAC_T46 902-905 "http://rdf.glycoinfo.org/glycan/G99530XJ" denotes tri
GlycanIUPAC_T47 902-905 "http://rdf.glycoinfo.org/glycan/G64132OC" denotes tri
GlycanIUPAC_T48 902-905 "http://rdf.glycoinfo.org/glycan/G96071SL" denotes tri
GlycanIUPAC_T49 902-905 "http://rdf.glycoinfo.org/glycan/G11932TO" denotes tri
GlycanIUPAC_T50 902-905 "http://rdf.glycoinfo.org/glycan/G71952HE" denotes tri
GlycanIUPAC_T51 902-905 "http://rdf.glycoinfo.org/glycan/G40960ZM" denotes tri
GlycanIUPAC_T52 902-905 "http://rdf.glycoinfo.org/glycan/G99023OP" denotes tri
GlycanIUPAC_T53 902-905 "http://rdf.glycoinfo.org/glycan/G75940FW" denotes tri
GlycanIUPAC_T54 902-905 "http://rdf.glycoinfo.org/glycan/G05449DN" denotes tri
GlycanIUPAC_T55 902-905 "http://rdf.glycoinfo.org/glycan/G12045NX" denotes tri
GlycanIUPAC_T56 902-905 "http://rdf.glycoinfo.org/glycan/G23531GF" denotes tri
GlycanIUPAC_T57 902-905 "http://rdf.glycoinfo.org/glycan/G83439GF" denotes tri
GlycanIUPAC_T58 902-905 "http://rdf.glycoinfo.org/glycan/G38120XA" denotes tri
GlycanIUPAC_T59 902-905 "http://rdf.glycoinfo.org/glycan/G09257XC" denotes tri
GlycanIUPAC_T60 902-905 "http://rdf.glycoinfo.org/glycan/G67867AY" denotes tri
GlycanIUPAC_T61 902-905 "http://rdf.glycoinfo.org/glycan/G70826LI" denotes tri
GlycanIUPAC_T62 902-905 "http://rdf.glycoinfo.org/glycan/G01893YT" denotes tri
GlycanIUPAC_T63 902-905 "http://rdf.glycoinfo.org/glycan/G57032UK" denotes tri
GlycanIUPAC_T64 902-905 "http://rdf.glycoinfo.org/glycan/G82566JW" denotes tri
GlycanIUPAC_T65 902-905 "http://rdf.glycoinfo.org/glycan/G03647LB" denotes tri
GlycanIUPAC_T66 902-905 "http://rdf.glycoinfo.org/glycan/G30298YA" denotes tri
GlycanIUPAC_T67 902-905 "http://rdf.glycoinfo.org/glycan/G12237BJ" denotes tri
GlycanIUPAC_T68 902-905 "http://rdf.glycoinfo.org/glycan/G35293BQ" denotes tri
GlycanIUPAC_T69 902-905 "http://rdf.glycoinfo.org/glycan/G56939XC" denotes tri
GlycanIUPAC_T70 902-905 "http://rdf.glycoinfo.org/glycan/G57481VS" denotes tri
GlycanIUPAC_T71 902-905 "http://rdf.glycoinfo.org/glycan/G12760VJ" denotes tri
GlycanIUPAC_T72 902-905 "http://rdf.glycoinfo.org/glycan/G78749LG" denotes tri
GlycanIUPAC_T73 902-905 "http://rdf.glycoinfo.org/glycan/G18179BX" denotes tri
GlycanIUPAC_T74 902-905 "http://rdf.glycoinfo.org/glycan/G97803IP" denotes tri
GlycanIUPAC_T75 902-905 "http://rdf.glycoinfo.org/glycan/G98770PI" denotes tri
GlycanIUPAC_T76 902-905 "http://rdf.glycoinfo.org/glycan/G48944LU" denotes tri
GlycanIUPAC_T77 902-905 "http://rdf.glycoinfo.org/glycan/G68361HD" denotes tri
GlycanIUPAC_T78 902-905 "http://rdf.glycoinfo.org/glycan/G57043GW" denotes tri
GlycanIUPAC_T79 902-905 "http://rdf.glycoinfo.org/glycan/G68666JO" denotes tri
GlycanIUPAC_T80 902-905 "http://rdf.glycoinfo.org/glycan/G52284HH" denotes tri
GlycanIUPAC_T81 902-905 "http://rdf.glycoinfo.org/glycan/G48271RR" denotes tri
GlycanIUPAC_T82 902-905 "http://rdf.glycoinfo.org/glycan/G28222XB" denotes tri
GlycanIUPAC_T83 902-905 "http://rdf.glycoinfo.org/glycan/G69666WN" denotes tri
GlycanIUPAC_T84 902-905 "http://rdf.glycoinfo.org/glycan/G00846QB" denotes tri
GlycanIUPAC_T85 902-905 "http://rdf.glycoinfo.org/glycan/G34497XL" denotes tri
GlycanIUPAC_T86 902-905 "http://rdf.glycoinfo.org/glycan/G83093ZM" denotes tri
GlycanIUPAC_T87 902-905 "http://rdf.glycoinfo.org/glycan/G07756TT" denotes tri
GlycanIUPAC_T88 902-905 "http://rdf.glycoinfo.org/glycan/G26740FE" denotes tri
GlycanIUPAC_T89 902-905 "http://rdf.glycoinfo.org/glycan/G32930YQ" denotes tri
GlycanIUPAC_T90 902-905 "http://rdf.glycoinfo.org/glycan/G75215RK" denotes tri
GlycanIUPAC_T91 902-905 "http://rdf.glycoinfo.org/glycan/G98272YB" denotes tri
GlycanIUPAC_T92 902-905 "http://rdf.glycoinfo.org/glycan/G71155WF" denotes tri
GlycanIUPAC_T93 902-905 "http://rdf.glycoinfo.org/glycan/G56744IY" denotes tri
GlycanIUPAC_T94 902-905 "http://rdf.glycoinfo.org/glycan/G38394RH" denotes tri
GlycanIUPAC_T95 902-905 "http://rdf.glycoinfo.org/glycan/G11815AV" denotes tri
GlycanIUPAC_T96 902-905 "http://rdf.glycoinfo.org/glycan/G62676XB" denotes tri
GlycanIUPAC_T97 902-905 "http://rdf.glycoinfo.org/glycan/G96377XW" denotes tri
GlycanIUPAC_T98 902-905 "http://rdf.glycoinfo.org/glycan/G99347BR" denotes tri
GlycanIUPAC_T99 902-905 "http://rdf.glycoinfo.org/glycan/G70803WR" denotes tri
GlycanIUPAC_T100 902-905 "http://rdf.glycoinfo.org/glycan/G88778DU" denotes tri
GlycanIUPAC_T101 902-905 "http://rdf.glycoinfo.org/glycan/G07971EH" denotes tri
GlycanIUPAC_T102 902-905 "http://rdf.glycoinfo.org/glycan/G95272JN" denotes tri
GlycanIUPAC_T103 902-905 "http://rdf.glycoinfo.org/glycan/G55109ZG" denotes tri
GlycanIUPAC_T104 902-905 "http://rdf.glycoinfo.org/glycan/G71585SL" denotes tri
GlycanIUPAC_T105 902-905 "http://rdf.glycoinfo.org/glycan/G07197CP" denotes tri
GlycanIUPAC_T106 902-905 "http://rdf.glycoinfo.org/glycan/G17730NT" denotes tri
GlycanIUPAC_T107 902-905 "http://rdf.glycoinfo.org/glycan/G34903LH" denotes tri
GlycanIUPAC_T108 902-905 "http://rdf.glycoinfo.org/glycan/G65660GA" denotes tri
GlycanIUPAC_T109 902-905 "http://rdf.glycoinfo.org/glycan/G48172IK" denotes tri
GlycanIUPAC_T110 902-905 "http://rdf.glycoinfo.org/glycan/G20725CN" denotes tri
GlycanIUPAC_T111 902-905 "http://rdf.glycoinfo.org/glycan/G50853HE" denotes tri
GlycanIUPAC_T112 902-905 "http://rdf.glycoinfo.org/glycan/G18401GJ" denotes tri
GlycanIUPAC_T113 902-905 "http://rdf.glycoinfo.org/glycan/G89755ME" denotes tri
GlycanIUPAC_T114 902-905 "http://rdf.glycoinfo.org/glycan/G58581FW" denotes tri
GlycanIUPAC_T115 902-905 "http://rdf.glycoinfo.org/glycan/G84356OA" denotes tri
GlycanIUPAC_T116 902-905 "http://rdf.glycoinfo.org/glycan/G48553NO" denotes tri
GlycanIUPAC_T117 902-905 "http://rdf.glycoinfo.org/glycan/G86886IB" denotes tri
GlycanIUPAC_T118 902-905 "http://rdf.glycoinfo.org/glycan/G22655ST" denotes tri

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 35-40 http://purl.obolibrary.org/obo/UBERON_0007113 denotes venom
PD-UBERON-AE-B_T2 111-116 http://purl.obolibrary.org/obo/UBERON_0007113 denotes venom
PD-UBERON-AE-B_T3 187-192 http://purl.obolibrary.org/obo/UBERON_0007113 denotes venom
PD-UBERON-AE-B_T4 1196-1201 http://purl.obolibrary.org/obo/UBERON_0007113 denotes venom

Lectin-Jamboree

Id Subject Object Predicate Lexical cue
T1 665-671 lectin denotes lectin

Lectin-Jamboree-Sentence

Id Subject Object Predicate Lexical cue
T1 0-104 Sentence denotes N-linked oligosaccharides of cobra venom factor contain novel alpha(1-3)galactosylated Le(x) structures.
T2 105-255 Sentence denotes Cobra venom factor (CVF), a nontoxic, complement-activating glycoprotein in cobra venom, is a functional analog of mammalian complement component C3b.
T3 256-417 Sentence denotes The carbohydrate moiety of CVF consists exclusively of N-linked oligosaccharides with terminal alpha1-3-linked galactosyl residues, which are antigenic in human.
T4 418-527 Sentence denotes CVF has potential for several medical applications, including targeted cell killing and complement depletion.
T5 528-606 Sentence denotes Here, we report a detailed structural analysis of the oligosaccharides of CVF.
T6 607-807 Sentence denotes The structures of the oligosaccharides were determined by lectin affinity chromatography, antibody affinity blotting, compositional and methylation analyses, and high-resolution (1)H-NMR spectroscopy.
T7 808-995 Sentence denotes Approximately 80% of the oligosaccharides are diantennary complex-type, approximately 12% are tri- and tetra-antennary complex-type, and approximately 8% are oligomannose type structures.
T8 996-1202 Sentence denotes The majority of the complex-type oligosaccharides terminate in Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1, a unique carbohydrate structural feature abundantly present in the glycoproteins of cobra venom.

NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 411-416 OrganismTaxon denotes human 9606

Anatomy-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 35-40 Body_part denotes venom http://purl.obolibrary.org/obo/UBERON_0007113
T2 111-116 Body_part denotes venom http://purl.obolibrary.org/obo/UBERON_0007113
T3 187-192 Body_part denotes venom http://purl.obolibrary.org/obo/UBERON_0007113
T4 1196-1201 Body_part denotes venom http://purl.obolibrary.org/obo/UBERON_0007113